FDA Puts Clinical Hold On Gilead's Magrolimab/Azacitidine Combo Trials In Blood Cancer Settings
The
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
YOU WONT BELIEVE: 9 - What They Never Told You
Gilead Alleges Counterfeiting Network Sold Fake HIV Drugs
Gilead Sciences Inc (NASDAQ: GILD) said an unauthorized network of drug distributors and suppliers sold pharmacies more than $250 million of counterfeit versions of its HIV treatments over the last two years.
Benzinga ·
Gilead Withdraws Use Of Zydelig In Two Forms Of Blood Cancer In US
Gilead Sciences Inc (NASDAQ: GILD) recently notified the FDA of its decision to
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Benzinga
Barchart
The Independent UK
StockNews.com
MarketBeat
The Guardian - UK
Medical Daily
Euronews
International Business Times
Woman & Home
Inverse
Salon
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
